v3.23.1
Consolidated Statements of Shareholders' (Deficit) Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Performance Stock Units
Common Stock
Common Stock
Restricted Stock Units (RSUs)
Common Stock
Performance Stock Units
Additional Paid- in Capital
Additional Paid- in Capital
Restricted Stock Units (RSUs)
Additional Paid- in Capital
Performance Stock Units
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Other Comprehensive Loss
Balance (in shares) at Mar. 02, 2019       342,582,000                  
Balance (in shares) at Mar. 02, 2019                       (210,349,000)  
Balance at Mar. 02, 2019 $ 2,560,331 $ (40,700)   $ 3,426     $ 2,118,673     $ 11,112,887 $ (40,700) $ (10,616,045) $ (58,610)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (613,816)                 (613,816)      
Other comprehensive (loss) income, net of tax (6,299)                       (6,299)
Issuance of restricted shares, net (in shares)       370,000                  
Issuance of restricted shares, net       $ 4     (4)            
Vesting of stock units (in shares)       580,000                  
Vesting of stock units       $ 5     (5)            
Stock-based compensation expense, net 46,159           46,159            
Director fees paid in stock (in shares)       12,000                  
Director fees paid in stock 169           169            
Repurchase of common stock, including fees (in shares)                       (6,806,000)  
Repurchase of common stock, including fees (99,710)                     $ (99,710)  
Dividends declared (83,545)                 (83,545)      
Shares sold under employee stock option plans, net of tax (in shares)       139,000                  
Shares sold under employee stock option plans, net of tax 2,346     $ 1     2,345            
Balance (in shares) at Feb. 29, 2020       343,683,000                  
Balance (in shares) at Feb. 29, 2020                       (217,155,000)  
Balance at Feb. 29, 2020 1,764,935     $ 3,436     2,167,337     10,374,826   $ (10,715,755) (64,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (150,773)                 (150,773)      
Other comprehensive (loss) income, net of tax 9,309                       9,309
Dividends forfeited 1,200                 1,200      
Vesting of stock units (in shares)       344,000                  
Vesting of stock units       $ 4     (4)            
Stock-based compensation expense, net 32,344           32,344            
Accelerated share repurchase program (in shares)                       (15,833,000)  
Accelerated share repurchase program (375,000)           (47,550)         $ (327,450)  
Repurchase of common stock, including fees (in shares)                       (632,000)  
Repurchase of common stock, including fees $ (5,079)                     $ (5,079)  
Forfeiture of restricted shares, net (in shares)       (786,000)                  
Forfeiture of restricted shares, net       $ (8)     8            
Balance (in shares) at Feb. 27, 2021 109,621,000     343,241,000                  
Balance (in shares) at Feb. 27, 2021                       (233,620,000)  
Balance at Feb. 27, 2021 $ 1,276,936     $ 3,432     2,152,135     10,225,253   $ (11,048,284) (55,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (400,518)                 (400,518)      
Other comprehensive (loss) income, net of tax 7,904                       7,904
Dividends forfeited 421                 421      
Issuance of restricted shares, net (in shares)       618,000                  
Issuance of restricted shares, net       $ 6     (6)            
Vesting of stock units (in shares)           274              
Vesting of stock units           $ 3     $ (3)        
Stock-based compensation expense, net 27,655           27,655            
Accelerated share repurchase program (in shares)                       (200,000)  
Accelerated share repurchase program             47,550         $ (47,550)  
Director fees paid in stock (in shares)       7,000                  
Director fees paid in stock 138           138            
Repurchase of common stock, including fees (in shares)                       (13,982,000)  
Repurchase of common stock, including fees (358,923)                     $ (358,923)  
Balance (in shares) at Nov. 27, 2021       344,140,000                  
Balance (in shares) at Nov. 27, 2021                       (247,802,000)  
Balance at Nov. 27, 2021 $ 553,613     $ 3,441     2,227,469     9,825,156   $ (11,454,757) (47,696)
Balance (in shares) at Feb. 27, 2021 109,621,000     343,241,000                  
Balance (in shares) at Feb. 27, 2021                       (233,620,000)  
Balance at Feb. 27, 2021 $ 1,276,936     $ 3,432     2,152,135     10,225,253   $ (11,048,284) (55,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (559,623)                 (559,623)      
Other comprehensive (loss) income, net of tax 9,586                       9,586
Dividends forfeited 461                 461      
Issuance of restricted shares, net (in shares)       624,000                  
Issuance of restricted shares, net       $ 6     (6)            
Vesting of stock units (in shares)       274,000                  
Vesting of stock units       $ 3     (3)            
Stock-based compensation expense, net 36,080           36,080            
Accelerated share repurchase program (in shares)                       (200,000)  
Accelerated share repurchase program             47,550         $ (47,550)  
Director fees paid in stock (in shares)       7,000                  
Director fees paid in stock 138           138            
Repurchase of common stock, including fees (in shares)                       (28,347,000)  
Repurchase of common stock, including fees $ (589,433)                     $ (589,433)  
Balance (in shares) at Feb. 26, 2022 81,979,000     344,146,000                  
Balance (in shares) at Feb. 26, 2022                       (262,167,000)  
Balance at Feb. 26, 2022 $ 174,145     $ 3,441     2,235,894     9,666,091   $ (11,685,267) (46,014)
Balance (in shares) at Aug. 28, 2021       343,596,000                  
Balance (in shares) at Aug. 28, 2021                       (242,536,000)  
Balance at Aug. 28, 2021 934,234     $ 3,436     2,218,400     10,101,522   $ (11,335,845) (53,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (276,429)                 (276,429)      
Other comprehensive (loss) income, net of tax 5,583                       5,583
Dividends forfeited 63                 63      
Issuance of restricted shares, net (in shares)       270,000                  
Issuance of restricted shares, net       $ 2     (2)            
Vesting of stock units (in shares)           274,000              
Vesting of stock units           $ 3     (3)        
Stock-based compensation expense, net 9,074           9,074            
Repurchase of common stock, including fees (in shares)                       (5,266,000)  
Repurchase of common stock, including fees (118,912)                     $ (118,912)  
Balance (in shares) at Nov. 27, 2021       344,140,000                  
Balance (in shares) at Nov. 27, 2021                       (247,802,000)  
Balance at Nov. 27, 2021 $ 553,613     $ 3,441     2,227,469     9,825,156   $ (11,454,757) (47,696)
Balance (in shares) at Feb. 26, 2022 81,979,000     344,146,000                  
Balance (in shares) at Feb. 26, 2022                       (262,167,000)  
Balance at Feb. 26, 2022 $ 174,145     $ 3,441     2,235,894     9,666,091   $ (11,685,267) (46,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (1,116,791)                 (1,116,791)      
Other comprehensive (loss) income, net of tax (2,533)                       (2,533)
Dividends forfeited 236                 236      
Issuance of restricted shares, net (in shares)       264,000                  
Issuance of restricted shares, net       $ 2     (2)            
Vesting of stock units (in shares)     640,000   1,063,000 177,000              
Vesting of stock units         $ 11 $ 2   $ (11) (2)        
Stock-based compensation expense, net 19,511           19,511            
Director fees paid in stock (in shares)       11,000                  
Director fees paid in stock 145           145            
Issuance of common stock and At-the-Market offering, net of offering costs (in shares)       36,678,000                  
Issuance of common stock and At-the-Market offering, net of offering costs 172,571     $ 367     172,204            
Repurchase of common stock, including fees (in shares)                       (2,850,000)  
Repurchase of common stock, including fees $ (45,927)                     $ (45,927)  
Balance (in shares) at Nov. 26, 2022 117,322,000     382,339,000                  
Balance (in shares) at Nov. 26, 2022                       (265,017,000)  
Balance at Nov. 26, 2022 $ (798,643)     $ 3,823     2,427,739     8,549,536   $ (11,731,194) (48,547)
Balance (in shares) at Aug. 27, 2022       345,053,000                  
Balance (in shares) at Aug. 27, 2022                       (264,691,000)  
Balance at Aug. 27, 2022 (577,654)     $ 3,450     2,253,039     8,942,368   $ (11,728,514) (47,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (392,966)                 (392,966)      
Other comprehensive (loss) income, net of tax (550)                       (550)
Dividends forfeited 134                 134      
Issuance of restricted shares, net (in shares)       (65,000)                  
Issuance of restricted shares, net       $ (1)     1            
Vesting of stock units (in shares)         496,000 177,000              
Vesting of stock units         $ 5 $ 2   $ (5) $ (2)        
Stock-based compensation expense, net 2,502           2,502            
Issuance of common stock and At-the-Market offering, net of offering costs (in shares)       36,678,000                  
Issuance of common stock and At-the-Market offering, net of offering costs 172,571     $ 367     172,204            
Repurchase of common stock, including fees (in shares)                       (326,000)  
Repurchase of common stock, including fees $ (2,680)                     $ (2,680)  
Balance (in shares) at Nov. 26, 2022 117,322,000     382,339,000                  
Balance (in shares) at Nov. 26, 2022                       (265,017,000)  
Balance at Nov. 26, 2022 $ (798,643)     $ 3,823     $ 2,427,739     $ 8,549,536   $ (11,731,194) $ (48,547)